Centre Francois Baclesse
Clinical trials sponsored by Centre Francois Baclesse, explained in plain language.
-
App aims to cut hospital phone tag for cancer patients
Disease control CompletedThis study tested whether adding a smartphone telemonitoring app called Cureety to usual cancer care could reduce the number of phone calls hospital staff need to make to patients. The calls are typically made before each chemotherapy session to check if patients are well enough …
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New hope for tough prostate cancers: old drug targets genetic weakness
Disease control CompletedThis study tested whether the chemotherapy drug carboplatin could help control advanced prostate cancer that had spread and stopped responding to standard hormone treatments. It focused on a small group of 16 men whose tumors had specific genetic changes that might make them more…
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC
-
Can learning about pain help cancer patients live better?
Symptom relief CompletedThis study tested whether a special education program could help cancer patients manage their pain better. 167 patients with cancer-related pain participated. One group received the educational workshops, while another received standard care, to see if learning more about pain ma…
Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Ear needles tested to ease breast cancer drug pain
Symptom relief CompletedThis study tested whether ear acupuncture (auriculotherapy) could reduce joint and muscle pain caused by common breast cancer medications called aromatase inhibitors. Researchers enrolled 197 postmenopausal women who had experienced this pain for at least three months. Participan…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
VR headset calms nerves before thyroid cancer surgery
Symptom relief CompletedThis study tested whether using a virtual reality headset with a calming hypnosis program could help reduce anxiety in patients before they had their thyroid removed. It involved 82 adults scheduled for total thyroidectomy, often for thyroid cancer. Researchers measured changes i…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC
-
VR headsets help cancer survivors fight 'Chemo Brain' and return to work
Symptom relief CompletedThis study tested whether a virtual reality (VR) program could help breast cancer survivors who have memory or concentration problems (often called 'chemo brain') return to or keep their jobs. Twenty-three patients who had finished cancer treatment within the last two years and w…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Mar 13, 2026 15:06 UTC
-
Chemotherapy's hidden toll: study reveals impact on cancer Survivors' daily lives
Symptom relief CompletedThis study looked at how chemotherapy affects the long-term quality of life for women treated for stage II or III endometrial cancer. Researchers compared 51 women who received chemotherapy plus radiation to those who received only radiation after surgery. The goal was to underst…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Mar 12, 2026 13:52 UTC
-
Walking machine trial aims to keep elderly cancer patients moving in hospital
Symptom relief CompletedThis study tested whether a special walking platform with safety features was practical for elderly cancer patients to use in the hospital. Researchers wanted to see if patients over 70 could complete at least two walking sessions during their stay. The goal was to help keep pati…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Mar 09, 2026 14:22 UTC
-
Chemo's sickening side effects under the microscope
Knowledge-focused CompletedThis study aimed to understand how often and how severely nausea and vomiting happen in cancer patients during their very first round of chemotherapy, even when they are given standard medications to prevent it. Researchers surveyed 300 adults in Normandy, France, who were starti…
Sponsor: Centre Francois Baclesse • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC